About InterGenetics

InterGenetics® is emerging as an innovator in the frontier of genetic medicine with a focus on improving women's health through genetics. InterGenetics'® research team has discovered proprietary gene combinations and DNA assessment technology leading to the first broad genetic predictive test for breast cancer, OncoVue®. InterGenetics® has a promising research pipeline of predictive tests for other cancers such as ovarian, colon, and prostate cancer. The company's core research has future application in also predicting heart disease, diabetes and in enhancing the effectiveness of drug therapies and preventative medicine in these fields.